Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.03
MMSI's Cash to Debt is ranked lower than
56% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.07 vs. MMSI: 0.03 )
MMSI' s 10-Year Cash to Debt Range
Min: 0.02   Max: No Debt
Current: 0.03

Equity to Asset 0.57
MMSI's Equity to Asset is ranked higher than
67% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. MMSI: 0.57 )
MMSI' s 10-Year Equity to Asset Range
Min: 0.44   Max: 0.84
Current: 0.57

0.44
0.84
Interest Coverage 3.46
MMSI's Interest Coverage is ranked higher than
51% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.42 vs. MMSI: 3.46 )
MMSI' s 10-Year Interest Coverage Range
Min: 1.49   Max: 7656.67
Current: 3.46

1.49
7656.67
F-Score: 6
Z-Score: 2.82
M-Score: -2.48
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 7.42
MMSI's Operating margin (%) is ranked higher than
73% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. MMSI: 7.42 )
MMSI' s 10-Year Operating margin (%) Range
Min: 3.78   Max: 19.22
Current: 7.42

3.78
19.22
Net-margin (%) 4.19
MMSI's Net-margin (%) is ranked higher than
71% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.99 vs. MMSI: 4.19 )
MMSI' s 10-Year Net-margin (%) Range
Min: 0.9   Max: 12.72
Current: 4.19

0.9
12.72
ROE (%) 5.08
MMSI's ROE (%) is ranked higher than
72% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.72 vs. MMSI: 5.08 )
MMSI' s 10-Year ROE (%) Range
Min: 2.45   Max: 22.81
Current: 5.08

2.45
22.81
ROA (%) 2.83
MMSI's ROA (%) is ranked higher than
71% of the 289 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.08 vs. MMSI: 2.83 )
MMSI' s 10-Year ROA (%) Range
Min: 1.15   Max: 18.64
Current: 2.83

1.15
18.64
ROC (Joel Greenblatt) (%) 10.33
MMSI's ROC (Joel Greenblatt) (%) is ranked higher than
69% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.54 vs. MMSI: 10.33 )
MMSI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 6.22   Max: 49.11
Current: 10.33

6.22
49.11
Revenue Growth (3Y)(%) 8.30
MMSI's Revenue Growth (3Y)(%) is ranked higher than
80% of the 262 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. MMSI: 8.30 )
MMSI' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0.9   Max: 19.7
Current: 8.3

0.9
19.7
EBITDA Growth (3Y)(%) 16.10
MMSI's EBITDA Growth (3Y)(%) is ranked higher than
86% of the 221 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. MMSI: 16.10 )
MMSI' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -9.2   Max: 51
Current: 16.1

-9.2
51
EPS Growth (3Y)(%) 3.70
MMSI's EPS Growth (3Y)(%) is ranked higher than
71% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.20 vs. MMSI: 3.70 )
MMSI' s 10-Year EPS Growth (3Y)(%) Range
Min: -16.5   Max: 157.1
Current: 3.7

-16.5
157.1
» MMSI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

MMSI Guru Trades in Q4 2013

Paul Tudor Jones 29,349 sh (New)
Steven Cohen 12,913 sh (New)
Jim Simons 184,112 sh (+56.01%)
Chuck Royce 1,743,906 sh (-2.91%)
» More
Q1 2014

MMSI Guru Trades in Q1 2014

Paul Tudor Jones 38,499 sh (+31.18%)
Jim Simons 236,947 sh (+28.7%)
Chuck Royce 1,809,406 sh (+3.76%)
Steven Cohen Sold Out
» More
Q2 2014

MMSI Guru Trades in Q2 2014

Paul Tudor Jones 49,267 sh (+27.97%)
Chuck Royce 1,877,406 sh (+3.76%)
Jim Simons 179,944 sh (-24.06%)
» More
Q3 2014

MMSI Guru Trades in Q3 2014

Paul Tudor Jones 52,092 sh (+5.73%)
Chuck Royce 1,944,906 sh (+3.6%)
Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MMSI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 34.10
MMSI's P/E(ttm) is ranked higher than
78% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 42.00 vs. MMSI: 34.10 )
MMSI' s 10-Year P/E(ttm) Range
Min: 12.95   Max: 64.78
Current: 34.1

12.95
64.78
P/B 1.71
MMSI's P/B is ranked higher than
86% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.38 vs. MMSI: 1.71 )
MMSI' s 10-Year P/B Range
Min: 1.08   Max: 7.07
Current: 1.71

1.08
7.07
P/S 1.46
MMSI's P/S is ranked higher than
85% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.74 vs. MMSI: 1.46 )
MMSI' s 10-Year P/S Range
Min: 1.03   Max: 4.81
Current: 1.46

1.03
4.81
PFCF 62.22
MMSI's PFCF is ranked higher than
76% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 57.37 vs. MMSI: 62.22 )
MMSI' s 10-Year PFCF Range
Min: 21.77   Max: 203.73
Current: 62.22

21.77
203.73
EV-to-EBIT 26.12
MMSI's EV-to-EBIT is ranked higher than
77% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.42 vs. MMSI: 26.12 )
MMSI' s 10-Year EV-to-EBIT Range
Min: 8.3   Max: 44.7
Current: 26.12

8.3
44.7
PEG 85.75
MMSI's PEG is ranked higher than
81% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. MMSI: 85.75 )
MMSI' s 10-Year PEG Range
Min: 0.45   Max: 240.57
Current: 85.75

0.45
240.57
Shiller P/E 32.12
MMSI's Shiller P/E is ranked higher than
86% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 139.22 vs. MMSI: 32.12 )
MMSI' s 10-Year Shiller P/E Range
Min: 15.59   Max: 84.24
Current: 32.12

15.59
84.24
Current Ratio 2.51
MMSI's Current Ratio is ranked higher than
68% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. MMSI: 2.51 )
MMSI' s 10-Year Current Ratio Range
Min: 1.82   Max: 5.18
Current: 2.51

1.82
5.18
Quick Ratio 1.26
MMSI's Quick Ratio is ranked higher than
60% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. MMSI: 1.26 )
MMSI' s 10-Year Quick Ratio Range
Min: 0.77   Max: 3.56
Current: 1.26

0.77
3.56

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.66
MMSI's Price/Tangible Book is ranked higher than
71% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.44 vs. MMSI: 5.66 )
MMSI' s 10-Year Price/Tangible Book Range
Min: 1.35   Max: 7.01
Current: 5.66

1.35
7.01
Price/DCF (Projected) 2.53
MMSI's Price/DCF (Projected) is ranked higher than
78% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.64 vs. MMSI: 2.53 )
MMSI' s 10-Year Price/DCF (Projected) Range
Min: 1.55   Max: 19.4
Current: 2.53

1.55
19.4
Price/Median PS Value 0.80
MMSI's Price/Median PS Value is ranked higher than
91% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.19 vs. MMSI: 0.80 )
MMSI' s 10-Year Price/Median PS Value Range
Min: 0.27   Max: 2.43
Current: 0.8

0.27
2.43
Price/Graham Number 2.95
MMSI's Price/Graham Number is ranked higher than
82% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. MMSI: 2.95 )
MMSI' s 10-Year Price/Graham Number Range
Min: 0.88   Max: 3.47
Current: 2.95

0.88
3.47
Earnings Yield (Greenblatt) 3.80
MMSI's Earnings Yield (Greenblatt) is ranked higher than
75% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.50 vs. MMSI: 3.80 )
MMSI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.2   Max: 12.1
Current: 3.8

2.2
12.1
Forward Rate of Return (Yacktman) 3.05
MMSI's Forward Rate of Return (Yacktman) is ranked higher than
66% of the 168 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.33 vs. MMSI: 3.05 )
MMSI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -3.4   Max: 37.2
Current: 3.05

-3.4
37.2

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:MM3.Germany,
Merit Medical Systems Inc was organized in July 1987 as a Utah corporation. The Company designs, develops, manufactures and sells medical devices used in interventional and diagnostic procedures. It provides its products to physicians and healthcare professionals to enhance patient care and enable them to perform procedures safely and effectively. Its operations are divided into the following principal markets: diagnostic and interventional cardiology, interventional radiology, interventional gastroenterology, interventional pulmonology, vascular surgery, interventional nephrology, and thoracic surgery. Its devices include Rad Board, Rad Board Xtra, Rad Trac and Rad Rest, which are used for patient positioning during radial access procedures; Safeguard Pressure Assisted Device, which assists in obtaining and maintaining hemostasis after a femoral procedure, and the Air-Band Radial Compression Device, which is indicated to assist hemostasis of the radial artery puncture site while maintaining visibility. The Company's products are also used in other clinical areas such as thoracic surgery, interventional nephrology, vascular surgery, and oncology and pain management. The Company offers safety-related products and kits. Its ShortStop and ShortStop Advantage Temporary Sharps Holders address the potential safety issues associated with accidental needle sticks. Its extensive line of color-coded Medallion Syringes and the PAL Pen and Label Medication Labeling System comply with patient safety initiatives of The Joint Commission and are designed to help minimize mix-ups in administering medication. It also offers waste management products to help avoid accidental exposure to contaminated fluids such as Occupational Safety and Health Administration compliant waste disposal basins: the BackStop, BackStop+, MiniStop, MiniStop+, and DugOut. The Company offer devices used to gain and maintain vascular access while protecting the clinician from accidental cuts and needle sticks during procedures such as the Futura Safety Scalpel and angiography needles such as the Merit Advance and the SecureLoc Safety Introducer Needle. It also offers sheath introducers such as Prelude and mini access kits such as MAK and S-MAK, designed to provide clinicians with smooth, less traumatic, and convenient access to the patient's vasculature. The Company offers the Clo-Sur PLUS P.A.D, intended for the local management of bleeding wounds and the creation of a barrier to bacterial penetration. It also offers two independent, differentiated radial compression systems, the Finale Compression Device and the RADStat Radial Artery Compression Device. Its diagnostic guide wires are used to traverse vascular anatomy and aid in placing catheters and other devices such as the pre-coated InQwire Diagnostic Guide Wires. The Merit Laureate Hydrophilic Guide Wire promotes rapid catheter exchanges and minimizes friction. It also offers the BowTie Guide Wire Insertion Device, us
» More Articles for MMSI

Headlines

Articles On GuruFocus.com
Merit Medical Systems Inc. (MMSI) CFO Kent W Stanger sells 15,870 Shares Feb 11 2011 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Dec 16 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Nov 17 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Oct 18 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Sep 16 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Aug 18 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Jul 19 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Jun 17 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares May 21 2010 
Merit Medical Systems Inc. (MMSI) COO Arlin D Nelson sells 8,335 Shares Sep 25 2009 


More From Other Websites
Nasdaq stocks posting largest percentage increases Dec 19 2014
Merit Medical Announces Multiple Regulatory Approvals Dec 10 2014
Merit Medical Announces Multiple Regulatory Approvals Dec 10 2014
Merit Medical to Participate at Piper Jaffray Healthcare Conference Nov 24 2014
Merit Medical to Participate at Piper Jaffray Healthcare Conference Nov 24 2014
MERIT MEDICAL SYSTEMS INC Financials Nov 18 2014
Merit Medical Up to Strong Buy on Impressive Q3 Performance Nov 13 2014
10-Q for Merit Medical Systems, Inc. Nov 12 2014
MERIT MEDICAL SYSTEMS INC Files SEC form 10-Q, Quarterly Report Nov 10 2014
Merit Medical to Present at Stephens and Canaccord Genuity Conferences This Month Nov 07 2014
Merit Medical to Present at Stephens and Canaccord Genuity Conferences This Month Nov 07 2014
Merit Medical Systems (MMSI) Upgraded From Hold to Buy Nov 04 2014
Merit Medical and Bard Access Systems, Inc. Settle Dispute Oct 30 2014
Merit Medical and Bard Access Systems, Inc. Settle Dispute Oct 30 2014
Merit Medical posts 3Q profit Oct 23 2014
Merit Medical posts 3Q profit Oct 23 2014
Merit Medical Systems Inc Earnings Call scheduled for 5:00 pm ET today Oct 23 2014
MERIT MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Oct 23 2014
Merit Medical Announces Results for the Quarter Ended September 30, 2014 Oct 23 2014
Merit Medical Announces Results for the Quarter Ended September 30, 2014 Oct 23 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK